Substance / Medication

Calcium glycerophosphate

Overview

Active Ingredient
calcium glycerophosphate
RxNorm CUI
1909

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

6 trials linked to this intervention

6
Total Trials
1
Recruiting
2
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Effect of the association of microparticles and nano-sized β-calcium glycerophosphate in conventional toothpaste on enamel remineralization: In situ study.
Emerenciano Nayara Gonçalves, Delbem Alberto Carlos Botazzo, Gonçalves Francyenne Maira Castro et al. · J Dent · 2023
PMID: 37741503RCT
In situ evaluation of low-fluoride toothpastes associated to calcium glycerophosphate on enamel remineralization.
Zaze A C S F, Dias A P, Amaral J G et al. · J Dent · 2014
PMID: 25220290Observational
Effect of a calcium glycerophosphate fluoride dentifrice formulation on enamel demineralization in situ.
Tenuta Livia Maria Andaló, Cenci Maximiliano Sergio, Cury Altair A Del Bel et al. · Am J Dent · 2009
PMID: 20225470Observational
Effect on mechanical and microbiological properties of adding calcium glycerophosphate and xylitol to glass ionomer cement.
de Azevedo Santana Juliana, de Lima Navarro Maria Fidela, Gomes Leonardo Fernandes et al. · Eur J Oral Sci · 2025
PMID: 39948433Other
Modification of restorative glass ionomer cement with zinc oxide nanoparticles and calcium glycerophosphate microparticles: in vitro assessment of mechanical properties and antimicrobial activity.
Meira Maria Fernanda Cavalcante, Fernandes Gabriela Leal Peres, DE Camargo Andréa Simone Stucchi et al. · J Appl Oral Sci · 2025
PMID: 41379137Other
Arginine combination with fluoride and calcium glycerophosphate: effects of concentration and on biofilm fluid.
Miranda Marina Lins, Salomão Karina Borges, Botazzo Delbem Alberto Carlos et al. · Future Microbiol · 2025
PMID: 39508342OtherFull text (PMC)
Effect of a New Formulation Bleaching Gel Containing Nanosized β-Calcium Glycerophosphate on Mechanical Properties, Color, and Cytotoxicity Response: In Vitro Study.
Fortunato Giovanna Lima, Rischka Klaus, de Oliveira Ribeiro Rafael Antonio et al. · J Esthet Restor Dent · 2025
PMID: 40589319Preclinical
Effect of nanometric β-calcium glycerophosphate supplementation in conventional toothpaste on enamel demineralization: An in vitro study.
Emerenciano Nayara Gonçalves, Delbem Alberto Carlos Botazzo, Gonçalves Francyenne Maira Castro et al. · J Mech Behav Biomed Mater · 2024
PMID: 38232670Preclinical
Enhanced anti-biofilm and anti-caries potential of arginine combined with calcium glycerophosphate and fluoride.
Miranda Marina Lins, Danelon Marcelle, Delbem Alberto Carlos Botazzo et al. · J Dent · 2024
PMID: 38714243Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Calcium glycerophosphate (substance)
SNOMED CT
20925001
UMLS CUI
C0006700
RxNorm CUI
1909

Clinical Data

This intervention maps to 3 entities in the Healos knowledge graph.

3
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
6
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.